Published: Oct, 2018

The demand within the global market for active pharmaceutical ingredients (APIs) has been rising on account of advancements in the pharmaceutical and healthcare industry, finds Transparency Market Research (TMR). The presence of a large number of vendors who deal in active pharmaceutical ingredients (API) has resulted in a highly fragmented competitor landscape. However, the fragmented nature of the global active pharmaceutical ingredients market has not affected the competition dynamics of this market, and the leading vendors have entered a neck-and-neck faceoff with each other. It is projected that the leading market vendors would tie up with pharmaceutical companies in order to gain the advantages of collaborative functioning. 

The newbie vendors in the global market for active pharmaceutical ingredients have been making ardent efforts to enhance their growth prospects in the market. Some of the key strategies adopted by these inexperienced and amateur market vendors are strategic alliances, prototyping of successful business models, and partnership with larger players. It is projected that the market vendors who fail to stay at par with the changing dynamics of the global market for active pharmaceutical ingredients would be acquired by the leading market players.

A report by Transparency Market Research (TMR) finds that the global market for active pharmaceutical ingredients would expand at a healthy CAGR of 6.40% over the period between 2017 and 2023. The net value of the market was US$151,591.7 in 2017, and this figure is expected to escalate to US$219,601.9 by 2023-end. On the basis of manufacturing process, captive manufacturing remains an attractive segment for the market. Based on geography, the demand for active pharmaceutical ingredients in North America has been on a rise over the past decade. 

active-pharmaceutical-ingredients.jpg

Focus on Quality Standards 

The medical industry has been battling the prevalence of chronic diseases across the world, and this has put pressure on the pharmaceutical industry to produce drugs and medications of the highest quality. This factor has played a pivotal role in the growth of the global market for active pharmaceutical ingredients and has taken the market demand to skyrocketing levels. Furthermore, the adherence of the pharmaceutical industry to the best practices for manufacturing has also emerged as a key propeller of market demand in recent times. Besides this, the adoption of safety standards in the pharmaceutical industry has also paved wya for the growth of the global market for active pharmaceutical ingredients. 

Off-Patent Drugs Impact Market Growth 

Several drugs produced by the pharmaceutical industry have run off-patent over the past few years, and this factor has negatively impacted the growth of the global market for active pharmaceutical ingredients. Furthermore, the pressure on the pharmaceutical industry to shorten the development time for drugs, bring down the cost of development, and adhere to quality standards without narrowing the profit margins has also been a roadblock for market growth. Nevertheless, the demand for geriatric drugs has continually escalated over the past decade, and this trend shall give a strong impetus to the growth of the global market for active pharmaceutical ingredients. 

The review is based on TMR’s report titled “Active Pharmaceutical Ingredients (API) Market (Manufacturing Process - Captive and Contract; API Type - Synthetic Chemical and Biological; Drug Type - Branded, Generic, and OTC; Therapeutic Area - Cardiovascular, Metabolic, Neurological, Oncology, Musculoskeletal, and NSAIDs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2023”. 

The market is segmented along the following lines: 

Global Active Pharmaceutical Ingredients (API) Market, By Manufacturing Process 

  • Captive Manufacturing
  • Contract Manufacturing 

Global Active Pharmaceutical Ingredients (API) Market, By API Type 

  • Synthetic Chemical API
  • Biological API 

Global Active Pharmaceutical Ingredients (API) Market, By Drug Type 

  • Branded Prescription Drugs
  • Generic Prescription Drugs
  • OTC Prescription Drugs 

Global Active Pharmaceutical Ingredients (API) Market, By Therapeutic Area 

  • Cardiovascular Disorders
  • Metabolic Disorders
  • Neurological Disorders
  • Oncology
  • Musculoskeletal Disorders
  • NSAIDs
  • Other Therapeutics Uses 

Global Active Pharmaceutical Ingredients (API) Market, By Geography 

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Rest of the World (RoW) 

About Us 

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. 

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories. 

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision. 

U.S. Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

.